C. Loge

发表

Perceived benefits of sharing health data between people with epilepsy on an online platform

M. Massagli, P. Wicks, J. Heywood, 2012, Epilepsy & Behavior.

Validation of the Pediatric Narcolepsy Screening Questionnaire (PNSQ): A cross-sectional, observational study.

G. Plazzi, J. Owens, C. Loge, 2022, Sleep medicine.

Sensitivity testing of the Seizure Severity Questionnaire (SSQ)

J. Cramer, S. Borghs, C. Loge, 2014, Epilepsy & Behavior.

A Long-Term Open-Label Extension Study Assessing Cognition and Behavior, Tolerability, Safety, and Efficacy of Adjunctive Levetiracetam in Children Aged 4 to 16 Years With Partial-Onset Seizures

Daniel B. Legoff, Hai-chen Yang, C. Loge, 2012, Journal of child neurology.

PND43 THE PATIENTSLIKEME® EPILEPSY COMMUNITY: A UNIQUE INSIGHT INTO THE LIVES OF PATIENTS WITH EPILEPSY

M. Massagli, P. Wicks, C. Loge, 2011 .

Brivaracetam in Unverricht‐Lundborg disease (EPM1): Results from two randomized, double‐blind, placebo‐controlled studies

F. Andermann, P. Genton, E. Andermann, 2016, Epilepsia.

Methods For Analyzing Patient-Reported Outcomes In Oncology Trials

B. Arnould, C. Loge, F. Fofana, 2016 .

Assessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trial

Hai-chen Yang, C. Loge, S. Hunter, 2010, Epilepsy & Behavior.

PatientsLikeMe® Online Epilepsy Community: Patient characteristics and predictors of poor health-related quality of life

P. Wicks, S. Borghs, C. Loge, 2016, Epilepsy & Behavior.

Development and Validation of an Acceptability and Satisfaction Questionnaire for a Contraceptive Vaginal Ring, NuvaRing®

C. Loge, A. Novák, L. Abetz, 2012, PharmacoEconomics.

Development and validation of a specific quality of life module in post-menopausal women with osteoporosis: The QUALIOST™

P. Marquis, C. Loge, P. Cialdella, 2004, Quality of Life Research.

Determining minimally important change thresholds for the Seizure Severity Questionnaire (SSQ)

J. Cramer, S. Borghs, C. Loge, 2014, Epilepsy & Behavior.

Defining minimally important change in QOLIE-31 scores: Estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures

J. Cramer, S. Borghs, C. Loge, 2012, Epilepsy & Behavior.

Understanding the Patient Perspective of Seizure Severity in Epilepsy: Development of a Conceptual Model

S. Borghs, C. Loge, K. Halling, 2016, The Patient - Patient-Centered Outcomes Research.

Use of Patient-Reported Outcomes (PROs) to Assess Prognosis, Toxicity, and Response: The Bortezomib Experience in Relapsed and Refractory Multiple Myeloma (MM).

D. Esseltine, D. Dubois, C. Loge, 2004 .

Health-related quality of life in double-blind Phase III studies of brivaracetam as adjunctive therapy of focal seizures: A pooled, post-hoc analysis

C. Brandt, S. Borghs, C. Loge, 2017, Epilepsy & Behavior.

Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders

D. Revicki, N. Talley, D. Dubois, 2004, Quality of Life Research.

The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability.

C. Loge, A Novák, C de la Loge, 2003, Contraception.

Long-term efficacy, safety, and tolerability, including behavior and executive functioning, during adjunctive lacosamide treatment in pediatric patients with uncontrolled epilepsy

C. Loge, Florin Floricel, C. Beller, 2024, Epilepsy & Behavior.